Scientific evidence indicates that beneficial microorganisms (that live in nearly ubiquitous communities called microbiota) are an essential component of human health, and could be a new frontier for personalised medicine to fight non-communicable diseases and improve human health. For their potential benefits to reach society, the EU should consider standardisation, protocols, and a regulatory framework to support research and innovation.